BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7430264)

  • 1. Erythroid progenitors forming clusters in vitro demonstrate high erythropoietin sensitivity.
    Ouellette PL; Monette FC
    J Cell Physiol; 1980 Oct; 105(1):181-4. PubMed ID: 7430264
    [No Abstract]   [Full Text] [Related]  

  • 2. Regeneration of erythroid committed precursor cells in polycythaemic mice treated with cyclophosphamide.
    Milenković P; Pavlović-Kentera V
    Exp Hematol; 1980 Jan; 8(1):44-51. PubMed ID: 7409037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroblasts derived in vitro from embryonic stem cells in the presence of erythropoietin do not express the TER-119 antigen.
    Otani T; Nakamura S; Inoue T; Ijiri Y; Tsuji-Takayama K; Motoda R; Orita K
    Exp Hematol; 2004 Jul; 32(7):607-13. PubMed ID: 15246156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors and hemopoiesis: Pandora's box revisited.
    Eaves CJ; Eaves AC
    Prog Clin Biol Res; 1984; 148():83-92. PubMed ID: 6379675
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropeptide modulation of murine erythropoiesis.
    Skelly RR; Fata J; Sharkis SJ; Sensenbrenner L; Ansari AA
    Ann Clin Lab Sci; 1987; 17(5):324-30. PubMed ID: 2823680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progenitor cells of erythroblasts: an in vitro investigation of erythropoietin-responsive cells of guinea pig bone marrow.
    Rosse C; Beaufait DW
    Anat Rec; 1978 Jun; 191(2):135-45. PubMed ID: 666014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroid progenitors in polycythemia vera.
    Varet B; Casadevall N; Lacombe C
    Blood Cells; 1981; 7(1):125-32. PubMed ID: 7187745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of erythropoietin as the inducer of erythroid differentiation.
    Goldwasser E
    Prog Clin Biol Res; 1985; 184():77-84. PubMed ID: 2996019
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro response to erythropoietin in erythroblastic transformation of chronic myelogenous leukemia.
    Greenberg BR; Hirasuna JD; Woo L
    Exp Hematol; 1980 Jan; 8(1):52-6. PubMed ID: 6931816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative patterns of erythropoiesis regulation].
    Tiazhelova VG; Akoev IG
    Izv Akad Nauk SSSR Biol; 1986; (5):704-20. PubMed ID: 3537053
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoiesis in the aged mouse: II. Response to stimulation in vitro.
    Udupa KB; Lipschitz DA
    J Lab Clin Med; 1984 Apr; 103(4):581-8. PubMed ID: 6699473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism underlying the inhibitory effect of dexamethasone on in vivo erythropoiesis.
    Giglio MJ; Alippi RM; Bozzini CE
    Exp Hematol; 1980 Aug; 8(7):911-6. PubMed ID: 16398023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic options of erythropoietin-stimulated erythropoiesis.
    Nijhof W; de Haan G; Pietens J; Dontje B
    Exp Hematol; 1995 Apr; 23(4):369-75. PubMed ID: 7895784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of various concentrations of erythropoietin on cultured erythroblast islands].
    Tishevskaia NV; Zakharov IuM; Tishevskoĭ IA
    Ross Fiziol Zh Im I M Sechenova; 1998 Dec; 84(12):1412-9. PubMed ID: 10204188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sl/Sld hematopoietic progenitors are deficient in situ.
    Barker JE
    Exp Hematol; 1994 Feb; 22(2):174-7. PubMed ID: 7507859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis.
    Burns S; Arcasoy MO; Li L; Kurian E; Selander K; Emanuel PD; Harris KW
    Blood; 2002 Jun; 99(12):4400-5. PubMed ID: 12036868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a murine bone marrow cell line producing a novel erythroid-enhancing activity.
    Royet J; Arnaud S; Blanchet JP
    Exp Hematol; 1996 Aug; 24(10):1201-8. PubMed ID: 8765495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.